Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.5 RB, SLActive? 8mm, RXD: medical device reports filed with FDA

1,790 reports name it, 2020–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,790
device reports naming the brand
0% of all MAUDE reports · about 279 a year
475
reports, 12 months to August 2026
455 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,790 medical device reports received by FDA name the brand "BLX ?3.5 RB, SLActive? 8mm, RXD" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from February 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

475 reports arrived in the 12 months to August 2026, close to the 455 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.6%), loss of osseointegration (17.2%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

051102Sep 2021: 11Oct 2021: 9Nov 2021: 15Dec 2021: 132022Jan 2022: 14Feb 2022: 5Mar 2022: 11Apr 2022: 12May 2022: 21Jun 2022: 8Jul 2022: 20Aug 2022: 18Sep 2022: 23Oct 2022: 23Nov 2022: 22Dec 2022: 172023Jan 2023: 25Feb 2023: 15Mar 2023: 19Apr 2023: 24May 2023: 22Jun 2023: 18Jul 2023: 19Aug 2023: 29Sep 2023: 19Oct 2023: 40Nov 2023: 42Dec 2023: 182024Jan 2024: 17Feb 2024: 22Mar 2024: 28Apr 2024: 16May 2024: 39Jun 2024: 21Jul 2024: 37Aug 2024: 28Sep 2024: 27Oct 2024: 54Nov 2024: 49Dec 2024: 302025Jan 2025: 29Feb 2025: 30Mar 2025: 37Apr 2025: 18May 2025: 0Jun 2025: 102Jul 2025: 39Aug 2025: 40Sep 2025: 30Oct 2025: 55Nov 2025: 39Dec 2025: 412026Jan 2026: 29Feb 2026: 41Mar 2026: 35Apr 2026: 48May 2026: 32Jun 2026: 57Jul 2026: 28Aug 2026: 40

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02304602020: 4720202021: 12120212022: 19420222023: 29020232024: 36820242025: 46020252026: 3102026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,790
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report84%1,503
Voluntary report0%0
User facility report0%0
Distributor report16%287
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,35475.6%62.8%
Loss of osseointegration30817.2%22.4%
Difficult to insertthe device was hard to insert90.5%0.4%
Fracturea broken bone30.2%1.6%
Difficult to removethe device was hard to remove10.1%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis63335.4%
Painpain, site not specified36020.1%
Inflammationinflammation1055.9%
Swelling/ edema884.9%
Hemorrhage/blood loss/bleeding874.9%
Fistula442.5%
Abscessa collection of pus422.3%
Hypersensitivity/allergic reaction311.7%
Hyperresponsive to stimuli231.3%
Tissue damage181%
Failure of implant50.3%
Swellingswelling50.3%
Numbnessnumbness30.2%
Sinus perforation30.2%
Inadequate osseointegration20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.5 RB, SLActive? 8mm, RXDProduct code DZEAll MAUDE reports
Reports1,7903,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer84%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.5 RB, SLActive? 8mm, RXD reports

How many FDA reports name BLX ?3.5 RB, SLActive? 8mm, RXD?

1,790 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 475 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.6%), loss of osseointegration (17.2%), difficult to insert (0.5%), fracture (0.2%) and difficult to remove (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (84%) and distributor reports (16%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.5 RB, SLActive? 8mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.